# wombat urls ß PLOS ONE: Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
Advertisement
Research Article

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

  • Richard J. Perrin equal contributor mail,

    equal contributor Contributed equally to this work with: Richard J. Perrin, Rebecca Craig-Schapiro

    rperrin@path.wustl.edu

    Affiliations: Division of Neuropathology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Rebecca Craig-Schapiro equal contributor,

    equal contributor Contributed equally to this work with: Richard J. Perrin, Rebecca Craig-Schapiro

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • James P. Malone,

    Affiliations: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Aarti R. Shah,

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Petra Gilmore,

    Affiliations: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Alan E. Davis,

    Affiliations: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Catherine M. Roe,

    Affiliations: Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Elaine R. Peskind,

    Affiliations: Department of Veterans Affairs Northwest Network Mental Illness Research, Education, and Clinical Center, University of Washington School of Medicine, Seattle, Washington, United States of America, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America

    X
  • Ge Li,

    Affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America

    X
  • Douglas R. Galasko,

    Affiliation: Department of Neurosciences, University of California at San Diego, San Diego, California, United States of America

    X
  • Christopher M. Clark,

    Affiliations: Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Alzheimer's Disease Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, United States of America

    X
  • Joseph F. Quinn,

    Affiliation: Layton Aging and Alzheimer's Disease Center, Oregon Health Science University, Portland, Oregon, United States of America

    X
  • Jeffrey A. Kaye,

    Affiliation: Layton Aging and Alzheimer's Disease Center, Oregon Health Science University, Portland, Oregon, United States of America

    X
  • John C. Morris,

    Affiliations: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • David M. Holtzman,

    Affiliations: Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • R. Reid Townsend,

    Affiliations: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Anne M. Fagan

    Affiliations: Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Published: January 12, 2011
  • DOI: 10.1371/journal.pone.0016032

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.